Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market 2025-10-13 21:40
iRegene Therapeutics announced promising NouvNeu001 Phase I clinical data 2025-10-13 21:00
NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain 2025-10-13 21:00
Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG 2025-10-13 21:00
Thousand Oaks Biologics Shanghai ADC Site receives EU QP Declaration 2025-10-13 20:00
ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease 2025-10-13 18:00
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine 2025-10-13 12:38
Smartee Launches World's First Sleep Aligner Combining Anti-Snoring Therapy with Teeth Alignment 2025-10-13 09:38
Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development 2025-10-13 08:10
C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001 2025-10-11 20:45
Renalys Announces Completion of Primary Endpoint Data Collection for Phase III Clinical Trial of Sparsentan for Iga Nephropathy in Japan 2025-10-10 14:00
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year 2025-10-10 08:30
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept) 2025-10-10 06:56
POMDOCTOR LIMITED Announces Closing of Initial Public Offering 2025-10-10 04:05
Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™ 2025-10-09 19:00
Advantech AOM-5721 Combines SMARC Design and Qualcomm Dragonwing™ QCS6490 for Next-Gen Edge AI 2025-10-09 17:05
EDAN Expands U.S. Operations with New Manufacturing Hub 2025-10-09 06:53
C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 2025 2025-10-08 22:20
Alpha Fusion and Kobe City Medical Center General Hospital Establish At-211 Investigational Drug Supply System 2025-10-08 21:00
POMDOCTOR LIMITED Announces Pricing of Initial Public Offering 2025-10-08 20:00
1 9 10 11 12 13 490